Serum Imatinib (Gleevec) Levels Predict GIST Response


George D. Demetri, M.D., Dana-Farber Cancer Institute in Bostonhttp://... -- Higher circulating levels of imatinib (Gleevec) correlated with better clinical responses in patients with gastrointestinal stromal tumors (GIST), but proper initial doses were unpredictable, a researcher reported here.







Channel: Education
Uploaded: February 1, 2008 at 9:00 am
Author: MedPageToday

Length: 00:03:01
Rating: 5.00
Views: 368

Tags: medicine health

Embed Code:


Video Comments:
No Comment
 

Privacy Policy Cancer Video | Treatment Survival & Education Copyright © 2007 All Rights Reserved.